Clinical aspects and risk factors of nosocomial Stenotrophomonas maltophilia bacteremia episodes in a Turkish intensive care unit

dc.contributor.authorTunger O.
dc.contributor.authorVural S.
dc.contributor.authorCetin C.B.
dc.contributor.authorKeles G.
dc.contributor.authorBorand H.
dc.contributor.authorGazi H.
dc.date.accessioned2024-07-22T08:23:02Z
dc.date.available2024-07-22T08:23:02Z
dc.date.issued2007
dc.description.abstractStenotrophomonas maltophilia is an important nosocomial pathogen with increasing frequency in recent years, especially in immunocompromised and clinically debilitated patients. The aim of this study is to describe the characteristics of 35 episodes of S. maltophilia bacteremia at Celal Bayar University hospital in Turkey over a 3-year period from January 2003 to December 2005. Cases were identified with microbiology laboratory records and clinical data were collected from the medical record of each patient. The source of bacteremia was central venous catheter (CVC) in 65.7% (23) and respiratory tract infection in 2.9% (1) of episodes while the source of bacteremia was unknown in 11 (31.4%) episodes of bacteremia. Factors significantly associated with mortality were age of ≥65 years, APACHE score of ≥16, the presence of the total parenteral nutrition, anemia, low creatinine clearance level and shock. The most sensitive antibiotic was found as trimethoprim-sulfamethoxazole (91.4%) in antibiotic susceptibility testing of the isolates. Susceptibilities of piperacillin-tazobactam and netilmicin which frequently used antibiotics as an empirical therapy were 62.8% and 68.6%, respectively. © E.S.I.F.T. srl.
dc.identifier.DOI-ID10.1179/joc.2007.19.6.658
dc.identifier.issn1120009X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19353
dc.language.isoEnglish
dc.publisherE.S.I.F.T. srl
dc.subjectamikacin
dc.subjectantibiotic agent
dc.subjectcefepime
dc.subjectceftazidime
dc.subjectceftriaxone
dc.subjectciprofloxacin
dc.subjectcotrimoxazole
dc.subjectimipenem
dc.subjectnetilmicin
dc.subjectpiperacillin plus tazobactam
dc.subjectprednisone
dc.subjecttimentin
dc.subjecttobramycin
dc.subjectadult
dc.subjectaged
dc.subjectanemia
dc.subjectantibiotic sensitivity
dc.subjectarticle
dc.subjectbacteremia
dc.subjectcentral venous catheter
dc.subjectclinical feature
dc.subjectcontrolled study
dc.subjectcreatinine blood level
dc.subjectdemography
dc.subjectdisease predisposition
dc.subjectfemale
dc.subjecthospital infection
dc.subjecthuman
dc.subjectinfection risk
dc.subjectintensive care unit
dc.subjectlaboratory test
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmedical record
dc.subjectmicrobiological examination
dc.subjectmortality
dc.subjectoutcome assessment
dc.subjectrespiratory tract infection
dc.subjectrisk factor
dc.subjectStenotrophomonas maltophilia
dc.subjecttotal parenteral nutrition
dc.subjectTurkey (republic)
dc.titleClinical aspects and risk factors of nosocomial Stenotrophomonas maltophilia bacteremia episodes in a Turkish intensive care unit
dc.typeArticle

Files